JNJ

167.36

+1.16%↑

NVS

115.01

+0.83%↑

ABT

127.26

-0.02%↓

TMO

462

-2.63%↓

ISRG

480.55

-1.3%↓

JNJ

167.36

+1.16%↑

NVS

115.01

+0.83%↑

ABT

127.26

-0.02%↓

TMO

462

-2.63%↓

ISRG

480.55

-1.3%↓

JNJ

167.36

+1.16%↑

NVS

115.01

+0.83%↑

ABT

127.26

-0.02%↓

TMO

462

-2.63%↓

ISRG

480.55

-1.3%↓

JNJ

167.36

+1.16%↑

NVS

115.01

+0.83%↑

ABT

127.26

-0.02%↓

TMO

462

-2.63%↓

ISRG

480.55

-1.3%↓

JNJ

167.36

+1.16%↑

NVS

115.01

+0.83%↑

ABT

127.26

-0.02%↓

TMO

462

-2.63%↓

ISRG

480.55

-1.3%↓

Search

Encompass Health Corp

Atvērts

SektorsVeselības aprūpe

108.68 -2.27

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

107.5

Max

111.57

Galvenie mērījumi

By Trading Economics

Ienākumi

33M

197M

Pārdošana

50M

1.5B

P/E

Sektora vidējais

22.051

40.048

EPS

1.37

Dividenžu ienesīgums

0.61

Peļņas marža

13.501

Darbinieki

28,572

EBITDA

37M

350M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+21.41% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

0.61%

2.45%

Nākamie ieņēmumi

2025. g. 4. aug.

Nākamais dividenžu datums

2025. g. 15. okt.

Nākamais Ex dividenžu datums

2025. g. 1. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

713M

11B

Iepriekšējā atvēršanas cena

110.95

Iepriekšējā slēgšanas cena

108.68

Ziņu noskaņojums

By Acuity

50%

50%

162 / 375 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bullish Evidence

Encompass Health Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 31. jūl. 23:56 UTC

Karstas akcijas

Stocks to Watch: Amazon, Bio-Rad, Coinbase, Mercer

2025. g. 31. jūl. 23:48 UTC

Tirgus saruna

Scentre Can Beat Annual Earnings Guidance -- Market Talk

2025. g. 31. jūl. 23:45 UTC

Tirgus saruna

Nikkei May Decline Amid Caution Over Earnings, Domestic Politics -- Market Talk

2025. g. 31. jūl. 23:37 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 31. jūl. 23:37 UTC

Tirgus saruna

Gold Steady as Traders Eye Tariff-Deal Developments -- Market Talk

2025. g. 31. jūl. 23:12 UTC

Peļņas

OCBC: Evolving Trade, Monetary Policies, Persistent Geopolitical Tensions Expected to Weigh on Growth Prospects >O39.SG

2025. g. 31. jūl. 23:10 UTC

Peļņas

Oversea-Chinese Banking: Declining Interest-Rate Environment Weighed in Net Interest Income >O39.SG

2025. g. 31. jūl. 23:09 UTC

Peļņas

Oversea-Chinese Banking 2Q Net Interest Income S$2.28B Vs. S$2.43B >O39.SG

2025. g. 31. jūl. 23:08 UTC

Peļņas

Oversea-Chinese Banking 2Q Total Income S$3.55B Vs. S$3.63B >O39.SG

2025. g. 31. jūl. 23:08 UTC

Peļņas

Oversea-Chinese Banking 2Q Net S$1.82B Vs. Net S$1.94B >O39.SG

2025. g. 31. jūl. 23:01 UTC

Peļņas

Amazon Posts Higher Sales, Profit -- 3rd Update

2025. g. 31. jūl. 22:08 UTC

Tirgus saruna
Peļņas

Amazon CEO Impressed by Deals Signed for Project Kuiper -- Market Talk

2025. g. 31. jūl. 22:02 UTC

Tirgus saruna
Peļņas

Apple's FY Outlook Shows Sales Growth Won't Last -- Market Talk

2025. g. 31. jūl. 21:57 UTC

Tirgus saruna
Peļņas

Amazon CEO Sees Strong Early Demand for Alexa+ -- Market Talk

2025. g. 31. jūl. 21:50 UTC

Peļņas

Amazon Earnings Beat Expectations. Why the Stock Is Falling. -- Barrons.com

2025. g. 31. jūl. 21:43 UTC

Peļņas

Apple's iPhone Sales Blow Past Estimates as Customers Raced to Beat Tariffs -- 2nd Update

2025. g. 31. jūl. 21:29 UTC

Peļņas

Amazon to Invest More in Chips, Data Centers Amid Generative AI Opportunity, CFO Says

2025. g. 31. jūl. 21:26 UTC

Peļņas

Apple Expects Revenue to Grow in Mid- to High-Single Digits in Current Quarter, CFO Says

2025. g. 31. jūl. 21:26 UTC

Peļņas

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

2025. g. 31. jūl. 21:22 UTC

Peļņas

Amazon Has Impressive Amount of Agreements for Project Kuiper, CEO Says

2025. g. 31. jūl. 21:19 UTC

Peļņas

Apple Estimates Tariff Impact to Add $1.1B to Costs in Current Quarter, CEO Says

2025. g. 31. jūl. 21:19 UTC

Peļņas

Apple Incurred $800M in Tariff-Related Costs in 2Q, CEO Says

2025. g. 31. jūl. 21:14 UTC

Peļņas

Amazon's AWS is Seeing More Demand Than Supply, CEO Says

2025. g. 31. jūl. 21:12 UTC

Peļņas

Amazon Saw Record Prime Sign-Ups in 3 Weeks Before Prime Day, CEO Says

2025. g. 31. jūl. 21:10 UTC

Peļņas

Amazon Just Getting Started on Automation, Robotics to Boost Efficiency, CEO Says

2025. g. 31. jūl. 21:09 UTC

Peļņas

Amazon Delivered to Prime Members at Record Pace in 2Q, CEO Says

2025. g. 31. jūl. 21:09 UTC

Peļņas

Amazon CEO Sees Diversity of Sellers as Advantage for Inflation-Weary Consumers

2025. g. 31. jūl. 21:08 UTC

Peļņas

Apple iPhone Revenue Performance Driven by Popularity of iPhone 16 Family, CEO Says

2025. g. 31. jūl. 21:08 UTC

Peļņas

Amazon CEO Sees Strong Customer Adoption of Perishables Same-Day Delivery Pilot

2025. g. 31. jūl. 21:05 UTC

Peļņas

Apple's iPhone Sales Blow Past Estimates as Customers Raced to Beat Tariffs -- Update

Salīdzinājums

Cenas izmaiņa

Encompass Health Corp Prognoze

Cenas mērķis

By TipRanks

21.41% augšup

Prognoze 12 mēnešiem

Vidējais 133.5 USD  21.41%

Augstākais 140 USD

Zemākais 129 USD

Pamatojoties uz 5 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Encompass Health Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

5 ratings

5

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

115.32 / 116.99Atbalsts un pretestība

Īstermiņā

Weak Bullish Evidence

Vidējā termiņā

Strong Bullish Evidence

Ilgtermiņā

Bullish Evidence

Noskaņojums

By Acuity

162 / 375 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Encompass Health Corp

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.